Newronika, Receives

Newronika Receives Investigational Device Exemption from FDA to Initiate U.S. Clinical Trial of Adaptive DBS System

Published on 08/07/2025 at 18:06 | prnewswire.co.uk

Newronika Spain Germany France United States of America Italy New York

or follow us on LinkedIn.

Logo - https://mma.prnewswire.com/media/2612569/5150136/Newronika_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/newronika-receives-investigational-device-exemption-ide-from-fda-to-initiate-us-clinical-trial-of-adaptive-dbs-system-302368037.html

en | boerse | 67961464 |